FR2751658B1 - USE OF A LIGAND CHEMOKINE (SDF-1) FOR LESTR / FUSIN / CXCR4 RECEPTOR TO PREVENT OR TREAT INFECTION WITH HIV-LIKE VIRUSES - Google Patents

USE OF A LIGAND CHEMOKINE (SDF-1) FOR LESTR / FUSIN / CXCR4 RECEPTOR TO PREVENT OR TREAT INFECTION WITH HIV-LIKE VIRUSES

Info

Publication number
FR2751658B1
FR2751658B1 FR9609477A FR9609477A FR2751658B1 FR 2751658 B1 FR2751658 B1 FR 2751658B1 FR 9609477 A FR9609477 A FR 9609477A FR 9609477 A FR9609477 A FR 9609477A FR 2751658 B1 FR2751658 B1 FR 2751658B1
Authority
FR
France
Prior art keywords
lestr
fusin
sdf
hiv
viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9609477A
Other languages
French (fr)
Other versions
FR2751658A1 (en
Inventor
Seisdedos Fernando Arenzana
Jean Louis Virelizier
Marco Baggiolini
Bernhard Moser
Lewis Ian Clark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR9609477A priority Critical patent/FR2751658B1/en
Priority to CA 2259948 priority patent/CA2259948A1/en
Priority to AU38547/97A priority patent/AU3854797A/en
Priority to EP97935637A priority patent/EP0917575A1/en
Priority to PCT/FR1997/001402 priority patent/WO1998004698A1/en
Publication of FR2751658A1 publication Critical patent/FR2751658A1/en
Application granted granted Critical
Publication of FR2751658B1 publication Critical patent/FR2751658B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
FR9609477A 1996-07-26 1996-07-26 USE OF A LIGAND CHEMOKINE (SDF-1) FOR LESTR / FUSIN / CXCR4 RECEPTOR TO PREVENT OR TREAT INFECTION WITH HIV-LIKE VIRUSES Expired - Fee Related FR2751658B1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9609477A FR2751658B1 (en) 1996-07-26 1996-07-26 USE OF A LIGAND CHEMOKINE (SDF-1) FOR LESTR / FUSIN / CXCR4 RECEPTOR TO PREVENT OR TREAT INFECTION WITH HIV-LIKE VIRUSES
CA 2259948 CA2259948A1 (en) 1996-07-26 1997-07-25 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection
AU38547/97A AU3854797A (en) 1996-07-26 1997-07-25 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection
EP97935637A EP0917575A1 (en) 1996-07-26 1997-07-25 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection
PCT/FR1997/001402 WO1998004698A1 (en) 1996-07-26 1997-07-25 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609477A FR2751658B1 (en) 1996-07-26 1996-07-26 USE OF A LIGAND CHEMOKINE (SDF-1) FOR LESTR / FUSIN / CXCR4 RECEPTOR TO PREVENT OR TREAT INFECTION WITH HIV-LIKE VIRUSES

Publications (2)

Publication Number Publication Date
FR2751658A1 FR2751658A1 (en) 1998-01-30
FR2751658B1 true FR2751658B1 (en) 1998-10-02

Family

ID=9494554

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9609477A Expired - Fee Related FR2751658B1 (en) 1996-07-26 1996-07-26 USE OF A LIGAND CHEMOKINE (SDF-1) FOR LESTR / FUSIN / CXCR4 RECEPTOR TO PREVENT OR TREAT INFECTION WITH HIV-LIKE VIRUSES

Country Status (5)

Country Link
EP (1) EP0917575A1 (en)
AU (1) AU3854797A (en)
CA (1) CA2259948A1 (en)
FR (1) FR2751658B1 (en)
WO (1) WO1998004698A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100387A (en) * 1997-02-28 2000-08-08 Genetics Institute, Inc. Chimeric polypeptides containing chemokine domains
US6852508B1 (en) 1997-02-28 2005-02-08 Genetics Institute, Llc Chemokine with amino-terminal modifications
MXPA00003885A (en) * 1997-10-22 2004-04-23 Inst Genetics Llc Chimeric polypeptides containing chemokine domains.
FR2771423A1 (en) * 1997-11-21 1999-05-28 Transgene Sa Recombinant viral vector expressing polypeptide that inhibits viral binding
WO2000009152A1 (en) * 1998-08-14 2000-02-24 The University Of British Columbia Therapeutic chemokine receptor antagonists
CA2305787A1 (en) 2000-05-09 2001-11-09 The University Of British Columbia Cxcr4 antagonist treatment of hematopoietic cells
CA2245224A1 (en) 1998-08-14 2000-02-14 Jiang-Hong Giong Chemokine receptor antagonists and chemotherapeutics
AU762472B2 (en) 1998-03-13 2003-06-26 University Of British Columbia, The Therapeutic chemokine receptor antagonists
DE1068357T1 (en) * 1998-03-30 2001-07-19 Northwest Biotherapeutics Inc THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BASED ON THE ROLE OF CXCR-4 IN TUMORGENESE
US6613742B1 (en) * 1999-04-07 2003-09-02 Thomas Jefferson University Chemokine-derived synthetic peptides
WO2001070173A2 (en) * 2000-03-23 2001-09-27 Phylomed Corporation Immunokine composition and method
US20050059584A1 (en) 2002-08-16 2005-03-17 Ahmed Merzouk Novel chemokine mimetics synthesis and their use
CA2335109A1 (en) * 2000-04-12 2001-10-12 Chemokine Therapeutics Corporation Cxcr4 agonist treatment of hematopoietic cells
US7378098B2 (en) 2000-04-12 2008-05-27 The University Of British Columbia CXC chemokine receptor 4 agonist peptides
US7368425B2 (en) 2006-03-24 2008-05-06 Chemokine Therapeutics Corp. Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
AU5811001A (en) * 2000-05-09 2001-11-20 Univ British Columbia Cxcr4 antagonist treatment of hematopoietic cells
WO2004094465A2 (en) * 2003-04-23 2004-11-04 The Board Of Trustees Of The University Of Illinois Office Of Technology Management University Of Illinois At Urbana-Champaign Synthetic molecules that mimic chemokines
IL164942A0 (en) * 2004-10-31 2005-12-18 Yeda Res & Dev The use of a protease or a protease inhibitor for the manufacture of medicaments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3367581B2 (en) * 1993-10-14 2003-01-14 小野薬品工業株式会社 Novel polypeptide, method for producing the same, DNA encoding the polypeptide, vector comprising the DNA, and host cells transformed with the vector

Also Published As

Publication number Publication date
WO1998004698A1 (en) 1998-02-05
AU3854797A (en) 1998-02-20
CA2259948A1 (en) 1998-02-05
EP0917575A1 (en) 1999-05-26
FR2751658A1 (en) 1998-01-30

Similar Documents

Publication Publication Date Title
FR2751658B1 (en) USE OF A LIGAND CHEMOKINE (SDF-1) FOR LESTR / FUSIN / CXCR4 RECEPTOR TO PREVENT OR TREAT INFECTION WITH HIV-LIKE VIRUSES
FR2716893B1 (en) Recombinant viruses, their preparation and their therapeutic use.
MA26790A1 (en) DIETETIC OR PHARMACEUTICAL COMPOSITION FOR USE IN THE PREVENTION OR TREATMENT OF HYPER-OXALURIA
BE901667A (en) ANALGESIC AND ANTI-INFLAMMATORY COMPOSITION BASED ON DIPHENHYDRAMINE, THEIR PREPARATION AND THEIR USE.
DZ1334A1 (en) Use of a composition for the surface treatment of floors.
FR07C0046I2 (en) BETA-L-2'-DESOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
DZ3014A1 (en) Medicines for the treatment of hypertension.
MA21739A1 (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION AND THE USE OF N-ACYCYSTEINS IN THE TREATMENT OF DISEASES ASSOCIATED WITH HIV INFECTIONS.
FR2597487B1 (en) AMORPHOUS COPOLYMERS OF HIGH MOLECULAR MASS OF ETHYLENE AND ALPHA-OLEFINS.
IL84790A (en) Pharmaceutical compositions containing 3)-deoxythymidin-2)-ene (3)-deoxy-2), 3)-didehydrothymidine) for treating patients infected with retroviruses
FR2792835B3 (en) USE OF SAREDUTANT FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OR PREVENTION OF ALL MOOD DISORDERS, ADAPTATION DISORDERS OR MIXED ANXIETY-DEPRESSION DISORDERS
OA09749A (en) "1-aryl-5- (substituted alkylideneimino) -pyrazoles pesticides, processes for their preparation, compositions containing them and their use".
FR2628097B1 (en) REFRACTORY MASSES OR CEMENTS, AND THEIR USE
FI944561A0 (en) HIV-neutralizing recombinant human monoclonal antibodies for the prevention and treatment of HIV infection
ITVR940096A0 (en) PROCEDURE AND EQUIPMENT FOR THE SPECIFIC IMMUNADORPTION OF HIV VIRUS, GP120 ANTIGEN AND CD4-GP120 COMPLEX.
BE1002310A4 (en) MEDICINE FOR THE TREATMENT OF OSTEOPOROSIS.
FR2722411B1 (en) IMMUNONANOPARTICLES COATED WITH ANTI-BETA2 MICROGLOBULIN MONOCLONAL ANTIBODIES AND THEIR USE FOR PROPHYLAXIS AND / OR THE TREATMENT OF PATHOLOGIES DUE TO HIV VIRUS INFECTION
FR2755975B1 (en) BICISTRONIC RECOMBINANT VIRUSES USEFUL FOR THE TREATMENT OF DYSLIPOPROTEINEMIA-RELATED CONDITIONS
FR2718024B1 (en) Medicine and pharmaceutical composition for the treatment of inflammation.
FR2571968B1 (en) VIRUS PURIFIES LYMPHADENOPATHIES AND ACQUIRED IMMUNO-DEPRESSION SYNDROME AND ENVELOPE ANTIGENS OF THIS VIRUS, VIRUS AND ENVELOPE ANTIGENS OF THIS VIRUS, APPLICATIONS OF THIS VIRUS OR ANTIGENS THEREOF PREPARATION OF IMMUNOGENIC COMPOSITIONS OR FOR THE DIAGNOSIS OF THE ABOVE CONDITIONS.
FR2704227B1 (en) IMMUNONANOPARTICLES CARRIING MONOCLONAL ANTI-CD4 ANTIBODIES AND THEIR USE FOR PROPHYLAXIS AND / OR THE TREATMENT OF CONDITIONS DUE TO HIV VIRUS INFECTION.
FR2602851B1 (en) ANTI-RETURN SYSTEM FOR ALL NON-PULSED OR ASPIRATED FLOW PIPES
OA08609A (en) Pharmaceutical composition for the treatment of bacterial infections.
BE1003340A3 (en) NEW THERAPEUTIC USE OF ALPHA-AMINOFLUOROCETONES.
FR2636229B1 (en) ELBOW SUPPORT FOR THE TREATMENT OF EPICONDYLITIS AND EPITROCHLEITIS

Legal Events

Date Code Title Description
ST Notification of lapse